EGFR and lung adenocarcinoma: Dynamic glyco-signature surfing: Differential sialoglycan patterns can distinguish TNBC sub-clones (BRCA-mutant vs. non-mutant) and have been exploited to circumvent wild-type EGFR down-regulation in EGFR-T790M lung adenocarcinoma [54,56].